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Despite its first appearance in 1962, human enterovirus D68 (EV-D68) has been
recognized as an emerging respiratory pathogen in the last decade when it caused
outbreaks and clusters in several countries including Japan, the Philippines, and the
Netherlands. The most recent and largest outbreak of EV-D68 associated with severe
respiratory illness took place in North America between August 2014 and January
2015. Between September 1 and October 31 2014, EV-D68 infection was laboratory
confirmed among 153/907 (16.9%) persons tested for the virus in Ontario, Canada,
using real time RT-PCR and subsequent genotyping by sequencing of partial VP1 gene.
In order to understand the evolutionary history of the 2014 North American EV-D68
outbreak, we conducted phylogenetic and phylodynamic analyses using available partial
VP1 genes (n = 469) and NCBI available whole genome sequences (WGS) (n = 38). The
global EV-D68 phylogenetic tree (n = 469) reconfirms the divergence of three distinct
clades A, B, and C from the prototype EV-D68 Fermon strain as previously documented.
Two sub-clades (B1 and B2) were identified, with most 2014 EV-D68 outbreak strains
belonging to sub-cluster B2b2 (one of the two emerging clusters within sub-clade B2),
with two signature substitutions T650A and M700V in BC and DE loops of VP1 gene,
respectively. The close homology between WGS of strains from Ontario (n = 2) and
USA (n = 21) in the recent EV-D68 outbreak suggests genetic relatedness and also a
common source for the outbreak. The time of most recent common ancestor of EV-D68
and the 2014 EV-D68 outbreak strain suggest that the viruses possibly emerged during
1960–1961 and 2012–2013, respectively. We observed lower mean evolutionary rates
of global EV-D68 using WGS data than estimated with partial VP1 gene sequences.
Based on WGS data, the estimated mean rate of evolution of the EV-D68 B2b cluster
was 9.75 × 10−3 substitutions/site/year (95% BCI 4.11 × 10−3 to 16 × 10−3).
Keywords: enterovirus D68, phylogenetic analysis, whole genome sequencing, cluster lineage, next-generation
sequencing, outbreak
Frontiers in Microbiology | www.frontiersin.org 1 March 2017 | Volume 8 | Article 257
fmicb-08-00257 February 27, 2017 Time: 16:48 # 2
Eshaghi et al. Evolutionary History of Enterovirus D68
INTRODUCTION
Enterovirus D68 (EV-D68) is a non-enveloped, positive-sense
single strand RNA virus belonging to species enterovirus D
of the Enterovirus genus within the Picornaviridae family.
Following its first isolation in 1962 from pediatric patients with
acute respiratory symptoms in the United States of America
(USA), EV-D68 has been detected with increasing frequency
in respiratory tract specimens (Schieble et al., 1967). Among
Enterovirus genus members, EV-D68 is the only serotype
with characteristics commonly found in rhinoviruses such as
acid lability and better growth at lower temperatures(33◦C)
(Blomqvist et al., 2002). Infection with EV-D68 can cause a
wide range of clinical presentations, from mild acute respiratory
illness (ARI), including influenza-like symptoms, to severe
acute lower respiratory tract infections such as pneumonia,
bronchiolitis and rarely death (Centers for Disease Control
and Prevention (CDC), 2011; Kreuter et al., 2011). Recent
studies suggested a possible aetiological role of EV-D68 in
meningitis and acute flaccid paralysis (AFP) (Lang et al., 2014).
Since 2006, clusters or outbreaks of ARI due to EV-D68 have
been documented worldwide in: China (2006 and 2008), the
Philippines (2008–2009), France (2009–2010), Japan (2010), USA
(2009 and 2014), Netherlands (1994–2010), Italy (2008–2014),
Thailand (2006–2011), and South Africa (2000–2001) (European
Centre for Disease Prevention and Control (ECDC), 2014; Piralla
et al., 2014). Compared to the small number of EV-D68 strains
detected from clinical specimens prior to 2006 (n= 26 from 1970
to 2005 in the USA), the increasing numbers of global outbreaks
since 2008 indicate the importance of EV-D68 as an emerging
respiratory pathogen (Rahamat-Langendoen et al., 2011; Tokarz
et al., 2011; Meijer et al., 2012).
Between 1991 and 2013, only 82 isolates of EV-D68
were reported by Public Health Agency of Canada-National
Microbiology Laboratory (PHAC-NML) (Booth et al., 2015;
Edwin et al., 2015). A study from Hamilton, ON, Canada
conducted during September to October of 2010 and 2011,
detected EV-D68 in 7% (7/92) and 1% (4/400) of self-collected
nasal swabs from university students with and without acute
respiratory symptoms, respectively (Granados et al., 2015). The
recent USA outbreak of EV-D68 started in August 2014, and
soon after reached Canada. The US Centers for Disease Control
and Prevention (CDC) reported 1,153 laboratory confirmed EV-
D68 cases in 49 states from mid-August 2014 to January 2015
(European Centre for Disease Prevention and Control (ECDC),
2014). This recent outbreak was the first experience of such a large
EV-D68 outbreak in Canada. From August to December 2014,
active sentinel and enhanced passive surveillance approaches
were conducted in Canada to assess the risk of 2014 EV-D68
infection along with its outbreak features (Skowronski et al.,
2015). In Canada, 268 pediatric hospitalized cases were reported
between September 1 and 30, 2014 from three provinces: Ontario
(n = 210), Alberta (n = 45), and British Columbia (n = 13)
(Edwin et al., 2015). In Ontario, EV-D68 was detected in 16.9%
(n = 153/907) of upper respiratory tract samples submitted to
Public Health Ontario Laboratories (PHOL) for testing between
September 1 and October 31, 2014. More than 50% of cases
were children below 5 years of age (median age 3 years) with
most (684/907; 75.6%) testing performed on children less than
10 years of age. Cases were not more likely to be hospitalized than
controls, and were more likely to be identified in September than
October (OR 8.07; 95% CI 5.15 to 12.64). There was no difference
in hospitalization status between cases and controls (Peci et al.,
2015).
The EV-D68 genome (approximately 7.5 kb in length)
contains a 5′ untranslated region (UTR) followed by a single open
reading frame and a short flanking 3′UTR non-coding region.
The polyprotein is processed by viral proteases, resulting in four
structural (VP4, VP2, VP3, and VP1) and seven non-structural
(2A, 2B, 2C, 3A, 3B, 3C, and 3D) proteins (Pallansch and Roos,
2007). Among the structural proteins, VP1 is considered an
important genotype determinant due to the presence of two loop
structures, BC and DE, on the viral surface. Their association with
enterovirus antigenic epitopes was previously reported (Norder
et al., 2003). Recent phylogenetic analysis of VP1 nucleotide
sequences indicates that three genetic groups, designated as
lineages 1, 2, and 3, or clades A, B, and C, are circulating
worldwide (Linsuwanon et al., 2012; Meijer et al., 2012; Tokarz
et al., 2012).
In this report, we studied the genetic diversity and
evolutionary history of EV-D68, with emphasis on the 2014
outbreak in Ontario. We carried out genotype classification
of EV-D68, lineage or clade global distribution, time of
the most recent common ancestor (tMRCA), and rate of
evolution using phylogenetic and phylodynamic analyses using
VP1 partial gene sequences and whole genome sequences
(WGS) from Ontario, and worldwide sequences available in
GenBank as of December 16, 2014. Furthermore, to determine
presence of genomic markers associated with this outbreak and
their possible association with rapid spread of EV-D68, the
complete genome of two representatives of EV-D68 strains from
Ontario were sequenced from clinical specimens using next-
generation sequencing (NGS) and compared to publicly available
genomes.
MATERIALS AND METHODS
Specimen Collection and Sequencing
Specimens submitted to PHOL for EV-D68 testing were collected
from patients who presented with respiratory symptoms in
different health care settings across Ontario. Early in the
outbreak, testing was performed at the PHAC-NML, and as of
October 8, 2014, testing was implemented at PHOL. Detection
of EV-D68 was performed by pan-enterovirus real-time reverse
transcription PCR (rRT-PCR) targeting 5′UTR followed by
partial VP1 gene sequencing to determine the molecular serotype
as previously described (Nix et al., 2006; Oberste et al., 2013).
Thirty-four EV-D68-positive specimens collected during the
2014 Ontario EV-D68 outbreak, which started in September
2014, were included in this study. Furthermore, to study the
genome characteristics of the 2014 EV-D68 outbreak in Ontario,
two primary specimens (NCBI accession numbers KT835407 and
KT835408), representing the two main genetic clusters based on
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sequence analysis of VP1 region, were selected for whole genome
sequencing.
For WGS, the extracted total nucleic acid from
nasopharyngeal swabs (NPS) was subjected to removal of
human rRNA using the NEBNext rRNA Depletion Kit (New
England Biolabs, Ipswich, MA, USA) (Morlan et al., 2012;
Adiconis et al., 2013). The DNA library was prepared using
the TruSeq RNA library preparation kit v2, normalized, and
run on the Illumina Miseq (Illumina, San Diego, CA, USA)
using the 2 × 150 bp paired-end reads option. Analysis of the
metagenomic data and identification of EV-D68 sequences
were performed using the SURPI (Sequence-based Ultra-Rapid
Pathogen Identification) pipeline and reference alignment using
bowtie2 (v2.2.5) (Langmead and Salzberg, 2012; Naccache
et al., 2014). Reference sequences were downloaded from NCBI
and SURPI’s curated databases. A consensus sequence was also
generated for each sample using the command “samtoolsmpileup
-ufref.faaln.bam | bcftools view -cg - | vcfutils.pl vcf2fq >cns.fq”
(Li et al., 2009; Li, 2011).
Sequence Data Set Construction
In our study, we used three discrete datasets of EV-D68 for
evolutionary analysis. These were named (1): WGS, containing
strains from clade B with available WGS in GenBank, between
1999 and 2014, and the Fermon reference strain (AY426531.1)
from 1967 (n = 38, two from Ontario, 21 from USA, and
15 from Other countries), (2): VP1-All includes all EV-D68
(n = 469, 34 from Ontario, and 435 from global), (3): VP1-
B2b (n = 74), only contains strains belonging to sub-clade B2b,
including the strains collected globally during the 2014 outbreak
(Supplementary Table S1).
As noted above, VP1-All consisted of 34 partial VP1 sequences
from the recent EV-D68 outbreak in Ontario and 435 EV-D68
VP1 gene partial sequences (339 bp of the hypervariable region
corresponding to nt positions 2521–2859 of the Fermon reference
strain AY426531.1) containing exact date of collection (from
1962 to 2014) retrieved from NCBI’s GenBank sequence database.
Although EV-D68 cases had been reported in Canada prior to
the 2014 outbreak, we did not find any submissions of Canadian
EV-D68 VP1 gene sequences in GenBank from prior to 2014.
Therefore, it is difficult to describe specific clades previously
circulating in Ontario.
Evolutionary Analyses
Phylogenetic analysis was carried out using the 469 partial VP1
EV-D68 nucleotide sequences (339 bp) using the Neighbor-
Joining method. Evolutionary distances were computed using
Maximum Composite Likelihood model between sequences
implemented in MEGA v6.06 (Tamura et al., 2013). A Bayesian
Markov chain Monte Carlo (MCMC) method implemented
in BEAST v1.8.0 (Drummond and Rambaut, 2007) was used
to construct Maximum Clade Credibility (MCC) trees and
estimate temporal phylogenies and rates of evolution. Both
strict and relaxed clocks (uncorrelated relaxed clock) were
employed with constant population size and Bayesian Skyline
plot (BSP) coalescent models to compare homogenous and
heterogeneous substitution rates across phylogenetic branches,
respectively (Drummond et al., 2006). The (continuous) gamma
model with substitution model HKY85 was used to estimate
evolution. The BEAST generated log and tree files were combined
and model convergence was ensured by confirming that the
effective sampling size (ESS) of all parameters was ≥200 by
using Tracer v1.6 (Rambaut et al., 2014). The uncertainty in the
estimates is indicated by 95% Bayesian Credible Interval (BCI)
values. Tree Annotator v1.8.0 program (included in BEAST)
was used to summarize the information in a sample of trees
by choosing the tree with the maximum product of posterior
probabilities. The Bayesian MCC phylogeny annotated with
divergence time, lineages, and evolutionary rate summaries was
used as a representation of the evolutionary history of EV-68
and phylogeny visualized using FigTree v1.4.21. Null (i.e., the
one with the lower marginal likelihood) and alternative models
were compared for their fit to the data using Bayes factors based
on the harmonic mean estimator as calculated by the program
Tracer v.1.4 from the BEAST package, where 2> Bayes factor≤ 6
indicates positive evidence against the null model; >6 > Bayes
factor ≤ 10 indicates strong evidence against the null model; and
Bayes factor > 10 indicates very strong evidence against the null
model (Kass and Raftery, 1995).
A phylogenetic network was computed with the 38 nearly
full-length EV-D68 genome sequences (Supplementary Figure
S1). A Neighbor-Net analysis and 1000 bootstrap replicates were
performed in SplitsTree 4.13.1 version (Bryant and Moulton,
2004; Huson and Bryant, 2006). The phi test analyzing probability
of statistically significant recombination was also performed in
SplitsTree.
Nucleotide Sequence and Accession
Numbers
Sequences obtained in this study have been submitted to NCBI’s
GenBank sequence database and have been assigned accession
numbers KT835373–KT835406 for partial VP1 gene sequences
and KT835407–KT835408 for WGS.
Ethics Statement
Specimens were collected from patients by submitters and sent
to PHOL for testing as part of routine clinical service. These
data are also used for routine laboratory surveillance, which is a
mandate of Public Health Ontario. Therefore, consultation with
our organization’s privacy office or ethics committee was not
required. To protect patient privacy and confidentiality, data are
reported in an anonymized format.
RESULTS
Phylogenetic Analysis of VP1 Genes of
EV-D68
Phylogenetic analysis with set VP1-All revealed the presence of
three distinct clades, A, B, and C, with supporting bootstrap
values of 86, 100 and 90%, respectively. Nucleotide and amino
1http://tree.bio.ed.ac.uk/software/figtree/
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acid identity within each clade was 88.9–100% and 88.4–100%
for clade A, 89.3–100% and 92.9–100% for clade B, and 94.1–
100% and 98.2–100% for clade C, respectively. EV-D68 strains
collected in Ontario during the 2014 outbreak belonged to sub-
clades B2 (n = 31), B1 (n = 2), and A2 (n = 1) indicating the
circulation of multiple sub-clades in Ontario during the same
period. The majority of Ontario strains clustered together with
USA strains from the same 2014 EV-D68 outbreak and fall into
clade B (33/34; 97%) and more specifically, sub-clade B2 (31/34;
91%).
The first EV-D68 sub-clade B2 strains reported globally were
from China and the Philippines in 2011. Sub-clade B1 contained
the two strains from Ontario and three USA strains from the
2014 outbreak. A distinct cluster was identified within sub-clade
B1, consisting of 2014 strains from The Netherlands and 2012
strains from Spain. The global sub-clade B2 sequences subdivide
into two distinct branches compiling clusters hereafter referred
to as B2.a (containing one strain from Ontario) and B2.b, with
the latter documented during the recent 2014 outbreak. Sub-
cluster B2.b2 contained the majority (24/34; 71%) of strains
from Ontario and USA (31/38; 82%) from the 2014 outbreak
(Figure 1). Strains within sub-cluster B2.b2 showed nucleotide
homology of 98.5–100%. Nucleotide identity of 97.3–99.7% was
obtained when B2.b2 were compared to the prototype Fermon
strain. Compared to the prototype Fermon strain, all Ontario
clade B sequences displayed the following substitutions: N642D,
A644T, S647A, G649Q, T650A, and H651D in the BC loop, and
N694S, N695S, D696N, S697N, and M700V in DE loop region
of VP1 (numbered from the first methionine of the polyprotein
gene). Our analysis showed that all strains in sub-cluster B2.b2
responsible for the outbreak in Ontario are distinguished by two
signature substitutions, T650A ( within the BC loop) and M700V
(within the DE loop). Interestingly, among the four available VP1
sequences of strains detected in patients with AFP from the USA
in NCBI’s GenBank sequence database, only one collected in 2014
(KM892502.1) clustered with strains of the 2014 outbreak from
USA and Ontario, within the main sub-cluster B2.b2.
Global Distribution of EV-D68 Lineages in
Time
Using available sequences in GenBank (as of December 16,
2014), the global distribution of EV-D68 along with its
period of detection, genotypes, clades and sub-clades were
mapped and color coded on a MCC tree according to the
place of isolation (Figures 2A,B). Lineages of strains with
available VP1 sequences from 19 countries (Cambodia, Canada,
China, Finland, France, Gambia, Iceland, Italy, Japan, Kenya,
Netherlands, New Zealand, the Philippines, Senegal, South
Africa, Spain, Thailand, UK, and USA) representing four
continents and spanning 53 years (1962–2014) were studied
(Figure 2C). Five (China, Italy, Japan, Netherlands, and USA)
of the 19 countries spanning three continents reported the
detection of all three EV-D68 clades (A, B, and C). The number
of deposited sequences per country were higher among these
five countries than all other countries (n = 22–123), except
Canada.
Phylogenetic Analysis of Whole Genome
Sequences of EV-D68
The full-length genome sequences of two Ontario specimens in
the present study were aligned with 36 genome sequences of EV-
D68 available from NCBI’s GenBank sequence database. When
comparing the WGS of the two Ontario strains representing
the two different sub-clusters, B2.b1 and B2.b2, they shared
substantial homology of 97.9 and 99.3% in nucleotide and amino
acid sequence of the complete polyprotein gene, respectively.
Several substitutions were identified within cluster B2.b and
between the members of sub-clusters B2.b1 and B2.b2 including
I746M, N770S (VP1 protein gene), A844T (p2A gene), S1166N,
S1379P (p2C protein gene), I1148V, L1491I (p3A protein
gene), D1594E and R1604K (p3D polymerase). Additional
mutations were also observed between the two Ontario strains
including S112P (VP2), N1142T (p2C), and K1582R (p3C gene).
Phylogenetic analysis of WGS data showed the distribution of
the three major clades of A, B, and C, with the two Ontario
strains belonging to clade B (Figure 3). These two Ontario strains
showed high identity to the strains isolated from the USA during
the 2014 outbreak with nucleotide and amino acid sequences
identities of 97.8–99.6 and 99.3–99.9%, respectively (Figure 4).
By using NCBI BLAST, isolate NY130 (NCBI accession
number KP745754.1), from the USA, and collected in September
2014, was found to be the closest strain to Ontario’s strains in sub-
clade B2.b2. Nucleotide sequence identity of 99.7% was obtained
between EV68/Ontario/C818710/2014 (NCBI accession number:
KT835407.1) and NY130. Nucleotide intra sub-clade identity of
98.9 and 97.8% was observed with the sub-clade B2.b1 and B2.b2
Ontario strains, respectively. Global strains representing each of
the two distinct sub-clades (B2.b1 and B2.b2) documented during
the 2014 outbreak showed highest and lowest nucleotide identity
of 99 and 93.9% within the p3C and p2B regions, respectively.
The phylogenetic network constructed by using a nearly full-
length EV-D68 sequences support the clustering of lineages
previously observed in the phylogenetic tree (Supplementary
Figure S1) and do not display edge (or split) supported by
bootstraps near the origin or within the sub-clade B2. Also, the
phi test did not show evidence of recombination (p= 0.72). These
findings suggest that the emergence of sub-lineage B2 is the result
of gradual acquisition of mutations rather than more complex
models of evolution such as recombination.
The Phylodynamic History of EV-D68
Genotype Using VP1 Gene and WGS
Data
The mean global estimates of evolutionary rates
(substitution/site/year), and tMRCA derived from constant
and BSP demographic models were implemented in BEAST
analyses for all three data sets, VP1-All (n = 469), VP1-B2b
(n = 78), and WGS (n = 38). As shown in Supplementary Table
S2, the Bayes factor strongly favors the strict molecular clock over
the relaxed molecular clock model with both WGS sets (Bayes
factor = 900.469) and VP1-All set (Bayes factor = 455.967),
indicating that EV-D68 viral strains may have evolved at similar
rates. The Bayes factor (2.76) for VP1-B2b set strongly favors
Frontiers in Microbiology | www.frontiersin.org 4 March 2017 | Volume 8 | Article 257
fmicb-08-00257 February 27, 2017 Time: 16:48 # 5
Eshaghi et al. Evolutionary History of Enterovirus D68
FIGURE 1 | Phylogenetic tree of EV-D68 detected globally and from Ontario, Canada. The phylogenetic tree based on the alignment of partial VP1
sequences (339 bp) of EV-D68 was inferred using the Neighbor-Joining method, evolutionary distances were calculated with the Maximum Composite Likelihood
method (MCL), and 1,000 Bootstrap replicates were computed to estimate the accuracy of the phylogenetic inference using MEGA v6.06
(http://www.megasoftware.net). Ontario sequences from this study are identified with red filled circles. Sequences collected in 2014 from the USA, Italy, and
Netherlands are marked with a blue square, green diamond, and light blue triangle, respectively. AFP sequences collected in 2013 obtained from GenBank are
labeled with a green circle. Bootstrap values > 60% are shown next to the nodes. Branch lengths are drawn to the indicated scale, proportion of nucleotide
substitutions per site. Some sub-clades are collapsed and labeled in bold to assist with visualization of other clades/sub-clades.
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FIGURE 2 | (A) Global distribution of EV-D68 as of December 2014. The location and corresponding year of specimen collection for EV-D68 VP1 sequences were
obtained from the NCBI GenBank sequence database and color coded by country. EV-D68 clades and sub-clades documented in each country were assigned
based on phylogenetic analysis of available partial (339 bp) VP1 nucleotide sequences as shown in Figure 1. Strains collected during 2014 are marked for Ontario
(red), USA (blue), Netherlands (cyan), and Italy (green). The editable vector map of the world template was downloaded (http://www.presentationmagazine.com/
world16maps-vector-editable-507.htm) and edited using PowerPoint and Adobe Photoshop. (B) The maximum clade credibility (MCC) tree of VP1 sequences of
available strains including the ones from Ontario visualized by FigTree. Branches are color coded according to the world map in (A). Temporal x-axis scale represents
the sampling dates. (C) Global distribution of clades, clusters and sub-clusters.
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FIGURE 3 | The phylogenetic relationships of the complete EV-D68 polyprotein gene (6567 nt) of Ontario strains (n = 2) to those available in NCBI’s
GenBank sequence database (n = 36). Topology was constructed using the Neighbor-Joining analysis and the evolutionary distances were computed using the
Maximum Composite Likelihood method available in MEGA v6.06. Bootstrap values (>70%) are shown as percentages derived from 1,000 samplings at the nodes
of the tree. The scale bar represents the number of nucleotide substitutions per site. Strains from Ontario are marked with solid black circles.
a relaxed molecular clock over a strict clock, indicating that
different strains may have evolved at significantly different rates
(Supplementary Table S2). Similarly, Bayes factors strongly
supported the BSP demographic model for each of WGS set,
VP1-All set and VP1-B2b set (Supplementary Table S3).
Table 1 provides estimated mean tMRCA and evolutionary
rates of EV-D68 based on the models that are strongly supported
by Bayes factor. The mean tMRCA estimates with sets WGS
[1960.42 (95% BCI 1957.67–1961.39)] and VP1-All [1961.79
(95% BCI 1960.76–1962.67)] overlap. Similar analysis with the
VP1-B2b set estimated the mean tMRCA to be 2012.60 (95% BCI
2011.84–2013.11). The mean rate of EV-D68 evolution using the
VP1-All set is estimated to be 4.98 × 10−3 substitution/site/year
(95% BCI 4.52 × 10−3 to 5.45 × 10−3). Using the WGS set;
the mean evolutionary rate is estimated to be 2.99 × 10−3
substitutions/site/year (95% BCI 2.61 × 10−3 to 3.30 × 10−3).
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FIGURE 4 | (A) Schematic representation of EV-D68 genome. The black bars represent the location of nucleotide variation within strains of clade B2.b2. Height
represents number of strains with specific nucleotide variation shown. (B) Nucleotide and amino acid identities between sub-clusters B2.b1 and B2.b2 (white area)
and between the complete genomes of two strains from Ontario belonging to sub-clades B2.b1 and B2.b2 (gray area).
The rate of evolution estimated for the recent EV-D68 emerging
strains (with VP1-B2b set) is 9.75 × 10−3 substitution/site/year
(95% BCI 4.11× 10−3 to 0.016) (Table 1).
DISCUSSION
Historically, EV-D68 virus has been detected sporadically, hence
was previously given less priority in routine surveillance by
national and international public health agencies. Mapping of
clades and sub-clades of EV-D68 virus from different outbreaks
from 1962 to 2014 demonstrated the infrequent occurrence and
spread of the virus (Figure 2). However, all three clades of EV-
D68 have been reported in China, Italy, Japan, Netherlands, and
the USA (Figure 2).
The recently emerged 2014 EV-D68 virus, belonging to
cluster B2.b of clade B (Figure 1), was widely spread
and caused severe respiratory illness across the USA and
Canada, disproportionately affecting persons with asthma. The
phylogenetic analyses demonstrated that strains from Ontario
and the USA grouped in cluster B2.b with the majority belonging
to a distinct sub-cluster B2.b2, suggesting a very close relationship
between the two adjacent outbreaks. The tree topology suggests
that there could have been multiple introductions of strains
within B2.b cluster to Ontario from the USA. Notably, all
strains from Ontario and USA in this emerging B2.b2 sub-cluster
contained two signature substitutions, T650A in the BC loop and
M700V in the DE loop of VP1 gene (correspond to positions
98 and 148 of the VP1 coding region) as previously reported
among strains circulating in the Philippines during 2013–2014
(Furuse et al., 2015). Further studies involving neutralization
and hemagglutination inhibition properties of recent strains
along with animal infection models are needed to determine if
these mutations play any role in transmissibility, antigenicity,
or virulence of the virus. Analysis of nucleotide diversity within
the complete polyprotein gene of strains from USA and Ontario
TABLE 1 | Whole genomic and VP1 gene based estimates of mean evolutionary history rates, and tMRCA for Enterovirus D68.
Mean evolutionary history rates
(×10−3 substitutions/site/year)
Root height (tMRCA in year)
95% BCI 95% BCI
Datasets Coalescent
method (clock)
Mean Lower Upper Mean decimal year
(mean date)
Lower Upper First time detected
(country)
Set WGS Bayesian Skyline
plot (SC)
2.99 2.61 3.3 (June 2, 1960) (September 2,1957) (May 23, 1961) 1962 (USA)
VP1-All Bayesian Skyline
plot (SC)
4.98 4.52 5.45 (October 16, 1961) (October 5, 1960) (September 2, 1962) 1963 (USA)
VPl-B2b Constant size
(RC)
9.75 4.11 0.016 (September 5, 2012) (November 3, 2011) (February 10, 2013) 2013 (USA)
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revealed that the p2C and p3C protein genes were the most
diverse coding regions of the genome, carrying three amino acid
substitutions.
The high VP1 sequence homology between strains of B2.a
and B2.b, and overlap of the estimated tMRCA of B2.b strains
(i.e., 2011–2013) with the detection time of B2.a strains (i.e.,
2011–2013 from China, Italy, Netherlands, Thailand, and AFP
strains from USA) may suggest emergence of B2.b sub-clade
either from or parallel to the B2.a strains. Similar observations
were noticed in the emergence of highly pathogenic H5N1 and
low pathogenic H5N1 viruses (Monne et al., 2014). A study from
Malaysia suggested that the North American EV-D68 outbreak
strain was probably descended from lineages of Thailand and
Malaysia (Ng et al., 2015).
Both Neighbor-Joining and Bayesian analysis of partial VP1
gene sequences (n = 469) from different outbreaks including
from Ontario identified three distinct phylogenetic clades (A, B,
and C), as previously reported (Tokarz et al., 2012). Genome-
scale phylogenetic analysis of the available EV-D68 WGS
(including strains from Ontario) showed similar tree topology
to that seen for the VP1 gene and supported the existence of
the same three clades. Furthermore, the reconstructed MCC
tree with set VP1-All showed similar NJ tree topology. Such
similarity indicates the selection of a correct and unbiased
model in our study, and further emphasizes the discriminatory
power of VP1 gene region as a marker in outbreak investigation
(Figures 1, 2B). The phylodynamic analyses with sets WGS
and VP1-All estimated similar tMRCAs, indicating that the EV-
D68 serotype possibly emerged during 1960–1961 or 1961–1962.
These estimates correlated with the previous estimates (Tokarz
et al., 2012), and are also closely in agreement with the time of
first isolation of EV-D68 (Fermon strain) in 1962 in the USA
(Schieble et al., 1967). In addition, tMRCA analysis with set VP1-
B2b determined that the EV-D68-B2b cluster (which contains the
2014 outbreak EV-D68 strains) as shown in Figures 1, 2 possibly
emerged during the 2012–2013 season.
Our Bayesian MCMC analyses with three different
datasets allowed us to compare the mean estimates of
evolution (substitution/site/year) of EV-D68. The mean
evolutionary rate of EV-D68 with VP1-All set (∼4.98 × 10−3
substitution/site/year) is higher than that of Set WGS
(∼2.99 × 10−3 substitutions/site/year). The higher estimate
of evolutionary rate with the VP1-All set can be attributed to its
evolutionary susceptibility, as it contains the antigenic epitopes
(Imamura et al., 2014). Similar differences in evolutionary
rate were also reported by Tan et al. (2013) and Duvvuri
et al. (2015), when they utilized the different length G-gene
sequences, and whole genomes of respiratory syncytial virus. Our
mean evolutionary estimate from VP1-All set [∼4.98 × 10−3
substitution/site/year (95% BCI 4.5–5.5) with a strict clock]
is at the lower bound when compared with the estimates
of Tokarz et al. (2012) [∼5.8 × 10−3 substitution/site/year
(95% BCI, 5.2–6.4) with a strict clock and ∼6.2 × 10−3
substitution/site/year (95% BCI, 5.4–7.1) with a relaxed clock].
This variation could be explained by the different number
and length of sequences utilized in the two analyses (Monne
et al., 2014), n = 210 with 928 bp; this study, n = 469
with 339 bp. The mean rate of evolution with VP1-B2b set
(n = 74) is ∼9.75 × 10−3 substitution/site/year (95% BCI
4.11× 10−3 to 1.6× 10−2), however, the wider credible intervals
indicate uncertainty due to limited sequence availability. Other
enteroviruses have been associated with respiratory illnesses.
For example, enterovirus C117, first identified in a child with
pneumonia in Lithuania in 2012, has been found in different
countries since and might be associated with respiratory tract
infections (Xiang et al., 2014; Van Leer-Buter et al., 2016).
Also, human enterovirus 71 (EV-71) is a known etiological
agent of hand, foot, and mouth disease and associated with
neurological complications. This serotype likely emerged in
1941 and displays substitution rate estimates ranging from 4.2
to 4.6 × 10−3/site/year, which is similar to EV-D68 (Tee et al.,
2010).
The majority of commercially available molecular assays do
not reliably distinguish between enterovirus and rhinovirus, both
members of the Enterovirus genus. The lack of serotyping of
enteroviruses in Canada prior to this outbreak resulted in an
unknown prevalence and impact of EV-D68 on the population
in the years prior to the outbreak. A Canadian study (2007–
2009) observed that acute respiratory infection caused by the
enterovirus-rhinovirus group had a more severe clinical course
compared to other viruses (Asner et al., 2014). It is unclear if a
proportion of those infections could have been caused by EV-
D68, as molecular serotyping was not performed in that study.
Molecular serotyping of previously collected respiratory samples
would contribute to better understanding the epidemiology of
EV-D68 in Canada (Granados et al., 2015). The impact of the
2014 EV-D68 North American outbreak emphasizes the need for
surveillance of respiratory viruses worldwide. This unexpected
event underscores the need for robust molecular serotyping
surveillance of enteroviruses, enabling improved serotype specific
understanding of virus circulation and disease burden.
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